Nucana Plc ADR (NCNA) Stock Price, Quote & News

Company Profile

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company is developing medicines to overcome the limitations of nucleoside analogs and generate anti-cancer metabolites in cancer cells. Its pipeline includes NUC-3373, a chemical entity derived from the nucleoside analog 5-fluorouracil that is in Phase...

Industry: Biotechnology

Sector: Healthcare

Phone: 44 13 1357 1111

Website: www.nucana.com

Address:

3 Lochside Way, Edinburgh, United Kingdom

ProfessorDman1 Oct. 4 at 2:45 PM

Watching Monday : $SLRX $SGBX $AREB $NCNA $QCLS

1 · Reply

GI812 Oct. 4 at 1:01 AM

$NCNA Up 18.48% last week with hopefully more to come. Oh yea, October 19th should be fun as well.

0 · Reply

Baseball89 Oct. 3 at 6:16 PM

$NCNA it's Friday and this thing should be over 5,000% by now. When CEO going to drop some news.

0 · Reply

Vikingsstrade Oct. 3 at 5:49 PM

$NCNA $ZBAI $HTCO $EVTV Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve.

0 · Reply

profitmaker007 Oct. 3 at 5:48 PM

$NCNA they can’t hold it down forever … be prepared …😎

0 · Reply

GI812 Oct. 3 at 5:26 PM

$NCNA Let's get to the magic 5 and hold it.

0 · Reply

Vikingsstrade Oct. 3 at 4:40 PM

$CDTX $NVVE $NCNA $BALY Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve.

0 · Reply

Chris11101 Oct. 3 at 3:26 PM

$NCNA 🤑🤑

0 · Reply

Baseball89 Oct. 3 at 3:15 PM

$NCNA Let's go this can very easy run 5,000% today.

1 · Reply

Chris11101 Oct. 3 at 2:57 PM

$NCNA yes 😁

0 · Reply

NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel

Oct 4, 2024, 12:03 PM EDT - 1 year ago

Baillie Gifford's Strategic Acquisition of NuCana PLC Shares

Sep 25, 2024, 4:01 PM EDT - 1 year ago

NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States

$NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024$